Ketoprofen S(+) enantiomer inhibits prostaglandin production and cell growth in 3T6 fibroblast cultures

European Journal of Pharmacology

Volumn 370, Issue 1, 1999, Pages 63-67

  Sánchez, Teresa ^a   Moreno, Juan J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Arachidonic acid; Cell proliferation; Cyclooxygenase; Eicosanoids; Growth factors

Indexed keywords

KETOPROFEN; PROSTAGLANDIN; PROSTAGLANDIN ENDOPEROXIDE; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENANTIOMER; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DINOPROSTONE; DNA; FIBROBLASTS; KETOPROFEN; MICE; STEREOISOMERISM; THYMIDINE;

EID: 0344507101     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00108-9     Document Type: Article

References (17)

1. Carabaza A., Cabrè F., Rotllan E., Gomez M., Gutierrez M., Garcia M.L., Mauleon D. Stereoselective inhibition of inducible cyclooxygenase by chiral non steroidal anti-inflammatory drugs. J. Clin. Pharmacol. 36:1996;505-512.
2. Chiu C.H., McEntee M.F., Whelan J. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res. 57:1997;4267-4273.
3. Domin J., Rozengurt E. Heterologous desensitisation of platelet-derived growth factor mediated arachidonic acid release and prostaglandin synthesis. J. Biol. Chem. 267:1992;15217-15223.
4. Domin J., Rozengurt E. Platelet-derived growth factor stimulates a biphasic mobilisation of arachidonic acid in Swiss 3T3 cells. J. Biol. Chem. 268:1993;8927-8934.
5. Honn V.K., Bockman R.S., Marnett L.J. Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins. 21:1981;833-864.
6. 2 is coupled to hormonally regulated release of arachidonic acid. Proc. Nat. Acad. Sci. U.S.A. 89:1993;6147-6151.
7. Lloret S., Torrent M., Moreno J.J. Proliferation-dependent changes in arachidonic acid mobilisation from phospholipids of 3T6 fibroblasts. Pflug. Arch. Eur. J. Physiol. 432:1996;655-662.
8. Lupulescu A. Enhancement of carcinogenesis by prostaglandins. Nature. 272:1978;634-636.
9. Marnett L.J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52:1992;5575-5589.
10. Martínez J., Sánchez T., Moreno J.J. Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth. Am. J. Physiol. 273:1997;C1466-C1471.
11. McCraken J.D., Wechter W.J., Liu Y., Chase R.L., Kantoci D., Murray E.D., Quiggle D.D., Mineyama Y. Antiproliferative effects of the enantiomers of flurbiprofen. J. Clin. Pharmacol. 36:1996;540-545.
12. Moreno J.J. Regulation of arachidonic acid release and prostaglandin formation by cell-cell adhesive interactions in wound repair. Pflug. Arch. Eur. J. Physiol. 433:1997;351-356.
13. Moreno, J.J., 1998. Role of arachidonic acid and eicosanoids in physiological and pathophysiological cell growth. In: Recent Research in Development in Lipids Research. Transworld Research Network, Trivandrum, India, pp. 73-79.
14. Moreno J.J., Calvo L., Fernández F., Carganico G., Bastida E. Biological activity of ketoprofen and its optical isomers. Eur. J. Pharmacol. 183:1990;2263-2264.
15. Reddy B.S., Nayini J., Tokumo K., Rigotty J., Zang E., Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,L-α-difluoromethylornitine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50:1990;2562-2569.
16. Rozengurt E. Early signals in the mitogenic response. Science. 234:1986;161-166.
17. Tsujii M., Kawano S., Dubois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3336-3340.